Medication info
Donegrin 5 mg (Donepezil Hydrochloride Hydrate)

Donegrin 5 mg (Donepezil Hydrochloride Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Donepezil Hydrochloride Hydrate›5mg / 1 tablet
Manufacturer / importer
Searus Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201902850 · Approved 2019.05.02 · Insurance code 689000700

Summary

Main use
Treatment of symptoms of Alzheimer's-type dementia
Who takes it
Adults · Children
Adult dose
Adults: Administer 5 mg of donepezil hydrochloride once daily before bedtime. If sleep disturbances such as unusual dreams, nightmares, or insomnia occur, morning administration of this medicine may be considered. Since donepezil reaches steady-state concentrations 15 days after administration and the incidence of adverse reactions may be affected by the rate of dose escalation, administer the 5 mg dose for 4~6 weeks. After evaluating the clinical response during this period, the dose may be increased to 10 mg. When increasing the dose to 10 mg once daily, administer with caution for gastrointestinal adverse reactions. If treatment with this medicine is discontinued, its effects gradually decrease, and no rebound effect occurs following abrupt discontinuation. Female patients aged 85 years or older with low body weight: Careful monitoring is required because adverse reactions occur frequently. Elderly women with low body weight should not receive more than 5 mg daily.
Child dose
Pediatrics: There is no experience with use in children.

Ingredients

Manufacturer
Searus Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of symptoms of Alzheimer's-type dementia

  • Symptoms of Alzheimer’s type dementia
View approved original text

This medication is used for the treatment of Alzheimer’s type dementia symptoms. It alleviates various symptoms such as memory decline and cognitive dysfunction caused by Alzheimer's disease, helping patients to manage their daily lives more smoothly. With consistent use, it helps to slow the progression of symptoms and improve quality of life.

How to take

Adult dose

Adults: Administer 5 mg of donepezil hydrochloride once daily before bedtime. If sleep disturbances such as unusual dreams, nightmares, or insomnia occur, morning administration of this medicine may be considered. Since donepezil reaches steady-state concentrations 15 days after administration and the incidence of adverse reactions may be affected by the rate of dose escalation, administer the 5 mg dose for 4~6 weeks. After evaluating the clinical response during this period, the dose may be increased to 10 mg. When increasing the dose to 10 mg once daily, administer with caution for gastrointestinal adverse reactions. If treatment with this medicine is discontinued, its effects gradually decrease, and no rebound effect occurs following abrupt discontinuation. Female patients aged 85 years or older with low body weight: Careful monitoring is required because adverse reactions occur frequently. Elderly women with low body weight should not receive more than 5 mg daily.

Child dose

Pediatrics: There is no experience with use in children.

Precautions

This medication contains donepezil hydrochloride as its main ingredient and is primarily used for the treatment of symptoms of Alzheimer’s type dementia. First, this medication should not be used in certain patients. For instance, individuals who are allergic to this medication, donepezil hydrochloride, piperidine derivatives, or any of its other components should not take it. Pregnant women or women who may become pregnant, as well as nursing mothers, should also avoid taking this medication. Since this medication contains lactose, individuals with genetic issues such as lactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption should not take it. Patients with heart disease should use this medication with caution. Particularly, those with sick sinus syndrome or atrioventricular conduction disturbances should be careful, as this medication may slow heart rate or cause arrhythmias. Additionally, patients with a history of peptic ulcers or those taking non-steroidal anti-inflammatory drugs should also exercise caution to prevent exacerbating gastrointestinal issues. Patients with a history of asthma or obstructive pulmonary disease should monitor for worsening symptoms due to the drug’s bronchoconstriction and increased mucus secretion. Patients with Parkinson’s disease or similar extrapyramidal disorders should take this medication cautiously, as it may worsen symptoms. This medication contains the dye Sunset Yellow FCF, and therefore, patients who are allergic to or sensitive to this component should be careful. While taking this medication, various adverse reactions may occur. Adverse cardiovascular effects reported include syncope, bradycardia, heart block, QT interval prolongation, myocardial infarction, and heart failure. Digestive system-related issues can manifest as peptic ulcers, duodenal perforation, and gastrointestinal bleeding. Liver dysfunction or symptoms of hepatitis should also be monitored, alongside serious neurological adverse effects such as seizures or intracerebral hemorrhage. Furthermore, severe side effects may occur, including symptoms of Parkinson’s disease and neuroleptic malignant syndrome, so anyone experiencing muscle pain or weakness should consult medical professionals immediately. Psychiatric adverse reactions may include hallucinations, agitation, aggressive behavior, anxiety, insomnia, drowsiness, depression, and confusion. Common gastrointestinal adverse reactions include nausea, vomiting, diarrhea, and abdominal pain, as well as possible skin rash or itching. As a cholinesterase inhibitor, this medication may stimulate the vagus nerve in the heart, potentially causing bradycardia or cardiac conduction abnormalities, necessitating regular check-ups including ECG for patients with a history of heart disease. Moreover, it enhances gastric acid secretion and increases gastrointestinal motility, which could worsen peptic ulcers, thus patients with a history of gastric diseases should take care. This medication can affect the ability to drive or operate machinery, so caution is needed during the initial phase of treatment or when changing the dosage. Pregnant or nursing mothers should abstain from using this medication, and if necessary, consultation with a medical professional regarding cessation of breastfeeding is recommended. The safety of this medication in children has not yet been established, and therefore it should not be used in pediatric patients. This medication is primarily metabolized in the liver, and may exhibit increased or decreased effects when taken with certain medications. Special caution is required when used in conjunction with drugs that inhibit or induce CYP3A4 or CYP2D6 enzymes. Additionally, co-administration with certain medications affecting cardiac conduction may increase the risk of arrhythmias; thus, patients should inform their healthcare providers. In case of overdose, severe cholinergic symptoms such as nausea, vomiting, sweating, bradycardia, hypotension, respiratory depression, and seizures may occur, and immediate medical treatment is essential. Atropine sulfate may be used as an antidote. Finally, this medication should be kept out of reach of children, and transferring it to another container may adversely affect its quality and should be avoided.

Side effects

Syncope, bradycardia, heart block, QT interval prolongation, myocardial infarction, heart failure, peptic ulcer, perforated duodenal perforation, gastrointestinal bleeding, hepatitis, liver dysfunction, jaundice, cerebral seizures, cerebral hemorrhage, cerebrovascular disorders, motor function disorders, ataxia, movement disorders, dystonia, tremors, involuntary movements, gait disorders, abnormal posture, speech disorders, psychomotor retardation, extreme muscle rigidity, dysphagia, tachycardia, blood pressure fluctuations, sweating, renal impairment accompanied by myoglobinuria, rhabdomyolysis, myalgia, weakness, dyspnea, acute pancreatitis, acute renal failure, unexplained sudden death, cold, loss of appetite, hallucinations, excitement, aggressive behavior, anxiety, insomnia, drowsiness, increased libido, talkativeness, mania, nightmares, nervousness, nonsensical speech, delusions, depression, confusion, apathy, hyperactivity, hypersexuality, dizziness, tremors, seizures, stupor, chest wall rigidity, palpitations, sinoatrial block, atrioventricular block, hypertension, hypotension, atrial fibrillation, torsades de pointes, diarrhea, nausea, vomiting, abdominal disorders, gastric and duodenal ulcers, constipation, salivation, fecal incontinence, rash, pruritus, muscle cramps, myalgia, urinary incontinence, frequent urination, urinary retention, headache, fatigue, pain, toothache, facial flushing, lethargy, asthenia, edema, fever, temperature decrease, decreased hematocrit, leukopenia, anemia, thrombocytopenia, petechiae, abnormal dreams, decreased appetite, urinary tract infection, increased CPK, dehydration, hyperlipidemia, insomnia, hostility, irritability, drowsiness, depression, confusion, emotional instability, personality disorders, eczema, urinary incontinence, accident, headache, pain, back pain, fever, chest pain, hypertension, bleeding, syncope, constipation, gastroenteritis, fecal incontinence, dyspepsia, increased γ-GT, gastritis, dysphagia, periodontitis, gastric ulcer, periodontal abscess, abdominal bloating, abnormal liver function, belching, esophagitis, anal bleeding, diabetes, anemia, leukocytosis, weight loss, peripheral edema, edema, increased LDH, increased alkaline phosphatase, hypercholesterolemia, hypokalemia, hypoglycemia, weight gain, hyperbilirubinemia, increased BUN, B12 deficiency anemia, cachexia, increased creatinine, gout, hyponatremia, hypoproteinemia, iron deficiency anemia, increased AST, increased ALT, arthritis, arthropathy, bone fracture, arthralgia, leg cramps, osteoporosis, agitation, anxiety, seizures, psychotic features, gait disturbances, apathy, delusions, dream abnormalities, cerebrovascular abnormalities, increased salivation, ataxia, euphoria, vasodilation, cerebral hemorrhage, cerebral infarction, cerebral ischemia, dementia, extrapyramidal symptoms, generalized tonic-clonic seizures, hemiplegia, hypertonia, hypokinesia, pharyngitis, pneumonia, increased cough, bronchitis, rhinitis, asthma, skin ulcer, psoriasis, skin discoloration, shingles, dry skin, urticaria, vesicular rash, conjunctivitis, glaucoma, visual disturbances, ear pain, lacrimal abnormalities, urinary tract infection, cystitis, hematuria, vaginitis, dysuria, proteinuria, abdominal pain, agitation, cholecystitis, confusion, seizures, heart block, hemolytic anemia, hyponatremia, neuroleptic malignant syndrome, pancreatitis, rash

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air and moisture, ideally at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness and prevent degradation.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.